Cytokinetics, IncorporatedCYTKNASDAQ
Loading
Book Value/Share Growth AcceleratingAccelerating
Percentile Rank62
Year-over-Year Change
Year-over-year book value per share growth
Percentile
P62
Within normal range
vs 2Y Ago
-1.7x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | -24.46% |
| Q3 2025 | -40.71% |
| Q2 2025 | -37.29% |
| Q1 2025 | -96.10% |
| Q4 2024 | -869.91% |
| Q3 2024 | -111.90% |
| Q2 2024 | 125.57% |
| Q1 2024 | 0.33% |
| Q4 2023 | 14.62% |
| Q3 2023 | -31.29% |
| Q2 2023 | -44.55% |
| Q1 2023 | -111.17% |
| Q4 2022 | -568.76% |
| Q3 2022 | -113.11% |
| Q2 2022 | -4.99% |
| Q1 2022 | -52.96% |
| Q4 2021 | -6.47% |
| Q3 2021 | 1253.02% |
| Q2 2021 | -75.89% |
| Q1 2021 | -40.47% |
| Q4 2020 | -26.94% |
| Q3 2020 | 267.26% |
| Q2 2020 | -69.85% |
| Q1 2020 | -317.10% |
| Q4 2019 | 45.43% |
| Q3 2019 | -298.96% |
| Q2 2019 | -238.08% |
| Q1 2019 | -87.03% |
| Q4 2018 | -50.25% |
| Q3 2018 | -31.16% |
| Q2 2018 | -24.85% |
| Q1 2018 | -9.55% |
| Q4 2017 | -25.59% |
| Q3 2017 | -24.58% |
| Q2 2017 | 58.21% |
| Q1 2017 | -1.34% |
| Q4 2016 | 11.52% |
| Q3 2016 | 69.67% |
| Q2 2016 | -15.98% |
| Q1 2016 | -18.02% |